Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neural Transm (Vienna) ; 119(11): 1267-74, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22350588

ABSTRACT

Sepsis is characterized by systemic biochemical alterations including the central nervous system in the early times and cognitive impairment at later times after sepsis induction in the animal model. Recent studies have shown that, besides its hematological activity, erythropoietin (EPO) has cytoprotective effects on various cells and tissues. In order to corroborate elucidating the effects of alternative drugs for sepsis treatment, we evaluated the effects of both acute and chronic EPO treatment on oxidative stress and energetic metabolism in the hippocampus, and cognitive impairment, respectively, after sepsis induction by cecal ligation and perforation (CLP). To this aim, male Wistar rats underwent CLP with "basic support" or sham operation. In the acute treatment, EPO was administered once immediately after CLP induction. The rats were then killed after 6 and 24 h, and the hippocampus was removed for analysis of oxidative stress and energetic metabolism, respectively. Regarding the chronic treatment, EPO was administered once daily until the 4th day after induction. Aversive memory was tested on the 10th day after surgery. It was observed that the acute use of EPO (a single dose) alters the oxidative parameters and energetic metabolism. Chronic use (4 days) reversed cognitive impairment in the sepsis animal model. Mortality rates were attenuated only during chronic treatment.


Subject(s)
Cognition Disorders/drug therapy , Energy Metabolism/drug effects , Erythropoietin/pharmacology , Erythropoietin/therapeutic use , Oxidative Stress/drug effects , Sepsis/metabolism , Analysis of Variance , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Citrate (si)-Synthase/metabolism , Cognition Disorders/etiology , Creatine Kinase/metabolism , Disease Models, Animal , Electron Transport/drug effects , Electron Transport Chain Complex Proteins/metabolism , Inhibition, Psychological , Ligation/adverse effects , Male , Rats , Rats, Wistar , Sepsis/complications , Sepsis/etiology , Statistics, Nonparametric , Time Factors
2.
Mol Neurobiol ; 45(2): 279-86, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22328136

ABSTRACT

Maple syrup urine disease is an inherited metabolic disease predominantly characterized by neurological dysfunction. However, the mechanisms underlying the neuropathology of this disease are still not defined. Therefore, the aim of this study was to investigate the effect of acute and chronic administration of a branched-chain amino acids (BCAA) pool (leucine, isoleucine, and valine) on acetylcholinesterase (AChE) activity and gene expression in the brain and serum of rats and to assess if antioxidant treatment prevented the alterations induced by BCAA administration. Our results show that the acute administration of a BCAA pool in 10- and 30-day-old rats increases AChE activity in the cerebral cortex, striatum, hippocampus, and serum. Moreover, chronic administration of the BCAA pool also increases AChE activity in the structures studied, and antioxidant treatment prevents this increase. In addition, we show a significant decrease in the mRNA expression of AChE in the hippocampus following acute administration in 10- and 30-day-old rats. On the other hand, AChE expression increased significantly after chronic administration of the BCAA pool. Interestingly, the antioxidant treatment was able to prevent the increased AChE activity without altering AChE expression. In conclusion, the results from the present study demonstrate a marked increase in AChE activity in all brain structures following the administration of a BCAA pool. Moreover, the increased AChE activity is prevented by the coadministration of N-acetylcysteine and deferoxamine as antioxidants.


Subject(s)
Acetylcholinesterase/blood , Amino Acids, Branched-Chain/metabolism , Antioxidants/pharmacology , Brain Chemistry/physiology , Maple Syrup Urine Disease/drug therapy , Maple Syrup Urine Disease/enzymology , Acetylcholinesterase/genetics , Amino Acids, Branched-Chain/toxicity , Animals , Antioxidants/therapeutic use , Brain Chemistry/drug effects , Disease Models, Animal , Male , Maple Syrup Urine Disease/chemically induced , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...